Purpose: The pharmacology, pharmacokinetics, efficacy, safety, drug interactions, dosage and administration, cost, and place in therapy of duloxetine for major depression, pain from diabetic ...
Hosted on MSN1mon
Duloxetine Recall: FDA Sets Second-Highest Risk Level for Antidepressants Containing Potential CarcinogenCertain bottles and doses of duloxetine, a common antidepressant, have been recalled due to the presence of potentially cancer-causing chemicals. The recall was initiated on Nov. 19 by ...
The U.S. Food and Drug Administration classified capsules of duloxetine, sold by New Jersey-based company Rising Pharmaceuticals, as a Class II risk on Dec. 5. The risk level is the FDA's second ...
More than 233,000 bottles of the antidepressant duloxetine have been recalled because of a chemical that contains the risk of cancer, public health officials said. The U.S. Food and Drug ...
Medpage Today on MSN9d
Gabapentin May Not Raise the Risk of Falling After AllNewer evidence has suggested, however, that gabapentin may not work for all pain conditions and is associated with falls. As ...
Find all the commercial and brand names of generic drug called Duloxetine. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...
The combined effects of duloxetine and MAOIs have not been evaluated in humans to date. It is recommended that duloxetine not be used in combination with an MAOI or within 14 days of discontinuing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback